Money Investment
            

Telik, Inc. - Common Stock

Stock Symbol:TELK

Public, NASDAQ:TELK

NASDAQ Global Market

TELK Stock Charts


Role of enzyme GSTP1-1 in progression of cancer, other diseases associated with increased cell proliferation
Date: Tue, 13 Jul 2010 13:48:48 GMT

Tags:

Role of enzyme GSTP1-1 in progression of cancer, other diseases associated with increased cell proliferation
News-Medical.net - Jul 13, 2010
Telik, Inc. (Nasdaq: TELK) today announced the publication of a review in the journal, Cell Death and Differentiation: Glutathione transferases as mediators of signaling pathways involved in cell ...

Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
Date: Mon, 12 Jul 2010 18:27:28 GMT

Tags:

Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
PR Newswire - Jul 12, 2010
PALO ALTO, Calif., July 12 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced the publication of a review in the journal, Cell Death and Differentiation: Glutathione transferases ...

Telik, Inc. (TELK) Corporate Event Announcement Notice
Date: Sat, 10 Jul 2010 01:24:46 GMT

Tags:

Telik, Inc. (TELK) Corporate Event Announcement Notice
Trading Markets - Jul 10, 2010
For full details on Telik Inc (TELK) TELK. Telik Inc (TELK) has Short Term PowerRatings at TradingMarkets. Details on Telik Inc (TELK) Short Term PowerRatings is available at This Link. Do you ...

Watch for Telik to Rebound after Falling 0.14% Yesterday (TELK)
Date: Fri, 09 Jul 2010 07:15:43 GMT

Tags:

Watch for Telik to Rebound after Falling 0.14% Yesterday (TELK)
Comtex Smartrend - Jul 9, 2010
By Chip Brian Telik (NASDAQ:TELK) traded in a range yesterday that spanned from a low of $0.68 to a high of $0.73. Yesterday, the shares fell 0.14%, which took the trading range below the 3-day ...

MAY v. TELIK, INC.
Date: Tue, 22 Jun 2010 12:52:23 GMT

Tags:

MAY v. TELIK, INC.
Leagle.com - Jun 22, 2010
STANLEY D. BERNSTEIN, Timothy J. MacFall, Ann Lipton, and Joseph R. Seidman, Jr., Bernstein Liebhard LLP, New York, New York, for Plaintiffs-Appellees, Policemen's Annuity and Benefit Fund of ...

TELIK INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfe (EDGAR Online)
Date: Thu, 29 Jul 2010 20:55:17 GMT

Tags:


Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments (PR Newswire)
Date: Mon, 12 Jul 2010 18:25:00 GMT

Tags:

Telik, Inc. today announced the publication of a review in the journal, Cell Death and Differentiation: Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death; http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201080a.html.  This review describes recent advances in the understanding of the important role that the enzyme GSTP1-1 plays in the progression of cancer and other diseases associated with increased cell proliferation.  Telintra®, Telik's investigational drug candidate inhibitor of GSTP1-1, has recently been reported to show positive results in a Phase 2 trial in patients with MDS, a disease characterized by disordered cell proliferation and differentiation.  Reprints of the publication are available from Telik.  
Telik Announces Publication of a Case Report of a Sustained Hematologic Response in Myelodysplastic Syndrome Following an Abbreviated Exposure to Oral Telintra(R) (Ezatiostat HCl) (PR Newswire)
Date: Mon, 21 Jun 2010 18:33:00 GMT

Tags:

Telik, Inc. today announced the publication of a case report by Quddus et al., Oral Ezatiostat HCl and Myelodysplastic Syndrome: A case report of sustained hematologic response following an abbreviated exposure.
Telik Announces Positive Phase 2 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Patients with Myelodysplastic Syndrome (PR Newswire)
Date: Tue, 08 Jun 2010 13:00:00 GMT

Tags:

Telik, Inc. today announced positive results from a Phase 2 multicenter trial of ezatiostat hydrochloride tablets in patients with an International Prognostic System Score low to intermediate-1 risk myelodysplastic syndrome .
Telik Announces Presentations and Webcasts at Investment Conferences (PR Newswire)
Date: Wed, 02 Jun 2010 20:05:00 GMT

Tags:

Telik, Inc. today announced that company management will provide corporate overviews at the following investment conferences:
Money Investment Provides Stock Market Headlines, Stock Quotes and Charts, Stock Exchange News and Prices.

Nasdaq   Dow Jones   BigCharts   E*Trade   ScotTrade   RSS Directory of Stock Quotes & Investing

© 2006 - 2010 MONEY INVESTMENT. ALL RIGHTS RESERVED.